Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Germing

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Annals of Hematology|November 7, 1999
Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myelomaG Kobbe, D Söhngen, U Bauser, et al.
Leukemia|March 23, 2013
Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantationT Schroeder, J Fröbel, R-P Cadeddu, et al.
Leukemia|February 3, 2007
Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classificationA Matsuda, U Germing, I Jinnai, et al.
Infection|August 28, 2013
Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitalsK S Schwab, C Hahn-Ast, W J Heinz, et al.
Leukemia|January 31, 2014
Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, E Lippert, A S Harutyunyan, et al.
European Journal of Haematology|June 20, 2002
Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cellsM Aivado, A Rong, M Stadler, et al.
Leukemia|April 19, 2013
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, T Alpermann, M Wulfert, et al.
Leukemia|March 21, 2012
Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblastsB H Yip, A Pellagatti, C Vuppusetty, et al.
Cytotherapy|March 15, 2005
Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemiaG Kobbe, R Fenk, F Neumann, et al.
Leukemia|December 25, 2004
Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinibF Neumann, N Teutsch, S Kliszewski, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Annals of Hematology|November 7, 1999
Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myelomaG Kobbe, D Söhngen, U Bauser, et al.
Leukemia|March 23, 2013
Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantationT Schroeder, J Fröbel, R-P Cadeddu, et al.
Leukemia|February 3, 2007
Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classificationA Matsuda, U Germing, I Jinnai, et al.
Infection|August 28, 2013
Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitalsK S Schwab, C Hahn-Ast, W J Heinz, et al.
Leukemia|January 31, 2014
Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, E Lippert, A S Harutyunyan, et al.
European Journal of Haematology|June 20, 2002
Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cellsM Aivado, A Rong, M Stadler, et al.
Leukemia|April 19, 2013
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, T Alpermann, M Wulfert, et al.
Leukemia|March 21, 2012
Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblastsB H Yip, A Pellagatti, C Vuppusetty, et al.
Cytotherapy|March 15, 2005
Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemiaG Kobbe, R Fenk, F Neumann, et al.
Leukemia|December 25, 2004
Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinibF Neumann, N Teutsch, S Kliszewski, et al.
Pageof 13